Malaria Roadmap Announced

Researchers should aim to develop a vaccine by 2030 that can reduce malaria cases by 75 percent and eventually eliminate the disease, according to a new roadmap launched this week.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

False-colored electron micrograph of a sporozoite migrating through the cytoplasm of midgut epitheliaWIKIMEDIA, IMAGE BY UTE FREVERT; FALSE COLOR BY MARGARET SHEARTo successfully eliminate malaria, which currently causes an estimated 660,000 deaths each year, researchers must develop vaccines that reduce cases by 75 percent, a new roadmap released Thursday (November 14) suggests.

“Safe, effective, affordable vaccines could play a critical role in defeating malaria,” Robert Newman, director of the World Health Organization’s Global Malaria Programme, said in a press release. “Despite all the recent progress countries have made, and despite important innovations in diagnostics, drugs and vector control, the global burden of malaria remains unacceptably high.”

The 2013 Malaria Vaccine Technology Roadmap, launched today at the annual conference of the American Society of Tropical Medicine & Hygiene in Washington, DC, and announced in The Lancet, is an update to a 2006 plan that focused on a Plasmodium falciparum vaccine for children in sub-Saharan Africa by 2015—a goal that very well may be met by GlaxoSmithKline’s RTS,S vaccine candidate, which last month scored high marks for protecting children ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control